FDA’s Ruling on Nicotine Raises Case for India to Commission Its Own Scientific Appraisal; Experts Back ICMR-Led Review

The U.S. Food and Drug Administration’s recent authorisation of modified-risk claims for certain non-combustible nicotine products is part of a broader international dialogue on strategies for tobacco and nicotine consumption. For India, the pivotal question is whether the country’s research inst...

First seen 56m ago · latest update 56m ago · India · science

Developing: this story surfaced recently from a single outlet. It appears early by design — expect the confidence score to move as more outlets report (or don’t).